TGFB1 and pulmonary fibrosis: Pulmonary fibrosis is further promoted by alveolar thrombosis and airway inflammatory viral injury, and SARS-CoV-2 can also induce pulmonary fibrosis by promoting the upregulation of TGF-β and other pro-fibrosis signaling molecules [11].